regulatory
confidence high
sentiment negative
materiality 0.50
Adaptive Biotechnologies Corp (ADPT): Nasdaq/NYSE listing notice — Adaptive Biotechnologies receives Nasdaq notice for Audit Committee non-compliance after director resignation
Adaptive Biotechnologies Corp
- On June 13, 2023, board member Leslie Trigg resigned, reducing Audit Committee to two members.
- Nasdaq rule 5605(c)(2)(A) requires at least three members on Audit Committee.
- Company received non-compliance notice on June 26, 2023, with a cure period to regain compliance.
- Company is evaluating board committee composition and intends to cure within the applicable period.